Align Technology ( (ALGN) ) has released its Q2 earnings. Here is a breakdown of the information Align Technology presented to its investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Align Technology, Inc., a prominent player in the medical device industry, specializes in designing and manufacturing the Invisalign System, iTero intraoral scanners, and exocad CAD/CAM software, catering to digital orthodontics and restorative dentistry.
In its second quarter of 2025, Align Technology reported total revenues of $1,012.4 million, reflecting a sequential increase of 3.4% but a year-over-year decline of 1.6%. The company experienced a mixed quarter with a notable rise in Imaging Systems and CAD/CAM Services revenues, while Clear Aligner revenues saw a slight decrease.
Key financial highlights include Clear Aligner revenues of $804.6 million, a 1.0% sequential increase but a 3.3% decline year-over-year. Imaging Systems and CAD/CAM Services revenues reached $207.8 million, marking a 13.9% sequential rise and a 5.6% year-over-year increase. Operating income stood at $163.0 million, with a GAAP operating margin of 16.1%. The company also reported a diluted net income per share of $1.72, with non-GAAP figures showing $2.49 per share.
Looking ahead, Align Technology anticipates continued economic uncertainty impacting demand for its products. The company plans strategic actions to streamline operations, including workforce realignment and manufacturing optimization, aiming to enhance long-term growth and profitability. These measures are expected to incur one-time charges but are projected to improve operating margins in the coming fiscal year.
Align Technology remains committed to leveraging its innovation and marketing strategies to navigate the challenging market conditions, focusing on driving engagement and effectiveness across its product lines, particularly targeting teens and kids.

